Norman Sharpe - Concepedia

Author

Norman Sharpe

Also Known As

M. Abernathy, M. Wargo, N SHARPE, N Sharpe, N. SHARPE, N. Sharpe, NORMAN SHARPE, Neil G. Sharpe, Norman Sharpe, Sharpe N

184

Publications

12.9K

Citations

H-Index

Concepts

All Affiliations

University of Auckland Auckland City Hospital Christchurch Hospital The George Institute for Global Health

About

Norman Sharpe is an author at University of Auckland specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	33	3.8K
2	Public Health	10	10	1.1K
3	Health Sciences	4	4	241
4	Education	1	1	14
5	Biomedical Engineering	1	1	107

Norman Sharpe

Publications

7.5K

Citations

H-Index

Page 1

	Year	Citations
Role of patients' view of their illness in predicting return to work and functioning after myocardial infarction: longitudinal study Keith J. Petrie, John Weinman, Norman Sharpe BMJ	1996	635
TREATMENT OF PATIENTS WITH SYMPTOMLESS LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION Norman Sharpe, Heather Smith, Judy Murphy, The Lancet Heart FailureCardiovascular DiseaseCardiac CareAcute Myocardial InfarctionMedicine	1988	482
Left Ventricular Remodeling With Carvedilol in Patients With Congestive Heart Failure Due to Ischemic Heart Disease fn1fn1This study was funded by a grant from SmithKline Beecham; however, the study was initiated, conducted, analyzed and reported by the Australia–New Zealand Heart Failure Research Collaborative Group independently of the sponsor. The Clinical Trials Research Unit is supported by a programme grant from the Health Research Council of New Zealand. Robert N. Doughty, Gillian Whalley, Greg Gamble, Journal of the American College of Cardiology CardiomyopathyHeart FailureSmithkline BeechamCardiorenal SyndromesCardiovascular Disease	1997	419
Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin Mark Richards, Robert N. Doughty, M. Gary Nicholls, Journal of the American College of Cardiology Adrenal GlandHypothalamic PeptideNeuroscienceEndocrinologyNeuropeptides	2001	388
Adverse Mortality Effect of Central Sympathetic Inhibition with Sustained-Release Moxonidine in Patients with Heart Failure (MOXCON) Jay N. Cohn, Marc A. Pfeffer, Jean L. Rouleau, European Journal of Heart Failure	2003	378
Effects of Carvedilol on Left Ventricular Remodeling After Acute Myocardial Infarction Robert N. Doughty, Gillian Whalley, Helen Walsh, Circulation	2004	322
Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition Norman Sharpe, Hans‐Jørgen Smith, Judy Murphy, The Lancet HypertensionHeart FailureEarly PreventionCardiovascular DiseaseLeft Ventricular Dysfunction	1991	307
Reliability of echocardiographic assessment of left ventricular structure and function Vittorio Palmieri, Björn Dahlöf, Vincent DeQuattro, Journal of the American College of Cardiology Left Ventricular StructureHeart FailureRadiologyStructural Heart DiseaseCardiovascular Disease	1999	300
Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease Tomohiro Katsuya, George Koike, Masatsugu Horiuchi, The Lancet EpidemiologyGenetic DeterminantCardiovascular EpidemiologyCardiovascular DiseaseGenetics	1995	300
Effects of Lowering Average or Below-Average Cholesterol Levels on the Progression of Carotid Atherosclerosis Stephen MacMahon, Norman Sharpe, Greg Gamble, Circulation	1998	264

Page 1